Cell Metabolism

With that in mind, I want to tell you about a study that was done out of the UC San Diego.

This was published in Cell Metabolism.

It was actually, the study was done by Dr. Sachin Panda.

So I've been really following some of his work recently.

And because you were coming on, I looked this up.

This is a study, this was published in the journal Cell Metabolism.

The title of the study, Effective Ultra Process Food Consumption on Male Reproductive and Metabolic Health.

And this was just published by the way.

Okay, here we go.

A cell metabolism study was published in 2019 looking at the power of a 36-hour fast followed by 12 hours of eating window.

So that's what they did.

They did 36 hours of fasting and then a 12-hour eating window.

What I also love about that study is that it really shows that we can bring inflammation down and that we can bring cholesterol down without medication.

That was just from fasting.

Cell metabolism, pretty cool, pretty cool study.

How do we go about preparing for a 36-hour fast so you get the maximum weight loss? Also, how do we break the fast so you keep the weight loss? So here we go.

One was published in one of the highest, both of them were published in very, very esteemed scientific medical journals.

One was in a journal called Cell Metabolism.

What they showed was that When people back in their food intake, so they consume most of the food that they eat during the day, later on during the day, into the evening, guess what it does to your hunger? It skyrockets it.

So if you're somebody who waits for later in the day, say 3 p.m. and on to eat, this is really important.

It has decades of safety data and observational work has repeatedly suggested that people taking it develop several age-related conditions at lower rates.

Barzali and colleagues laid out the case in the journal Cell Metabolism in 2016, and they talked about TAME, T-A-M-E, or Targeting Aging with Metformin, a trial in fact designed to enroll adults aged 65 to 79 and use a composite of age-related diseases as the endpoint rather than any singular disease.

The design point was as much regulatory as scientific.

Aging is not a recognized indication and no drug can currently be approved to treat it.

It sculpts who comes after you.

It was just published in Cell Metabolism.

And the results were jaw-dropping.

They divided male mice into two groups.

Thoughts? Anyway, warm up over.

Let's hit the main set.

So the paper in question, the one that we're going to discuss today, was just published in Cell Metabolism.

It builds on prior evidence that a father's exercise capacity and metabolic health can shape the exercise capacity and metabolic health of his offspring.

There's very good research that this is gonna dramatically lower your blood sugar, your A1C, and all the other markers I talked about earlier.

I linked down in the show notes, uh, to an article that was published in the very prestigious journal, Cell Metabolism.

There's a link in the show notes, check that out.

This is proven, and I've also seen hundreds of thousands of people, both in person and online, who have used time-restricted eating to improve their diabetes.

With that in mind, I want to tell you about a study that was done out of the UC San Diego.

This was published in Cell Metabolism.

It was actually, the study was done by Dr. Sachin Panda.

So I've been really following some of his work recently.

So what happens when data come out that go against the conventional viewpoint but doctors never get taught? So if you don't mind me indulging you in a complimentary example, I'll give you another, which was, um, and, and I'll tie in something else that people might know about GLP-1s.

When I was a third year at, at, at, um, Harvard Med and I was doing my rotations, uh, a human controlled trial came out in another top journal, Cell Metabolism, and the punchline was that statins, in fact, the most popular statin of all time, Atorvastatin, brand name Lipitor, critically lo- like smashes down GLP-1 levels in humans.

GLP-1 is the target, this axis of the blockbuster weight loss drugs.

Mm.